BioPharma

29 July, 2026 | Wednesday | News

HoneyNaps Expands Global CRO Services with AI-Powered Sleep Analytics Platform

Strengthens specialized AI-powered sleep data analysis services for global pharmaceutical, medical device, and healthcare companies Targets the rapidly growing global sleep clinical research market with adva...

Lab

30 July, 2026 | Thursday | News

Eppendorf to Invest EUR 40 Million in New Penang Manufacturing Facility

Eppendorf has signed an agreement for a new production site in Penang, Malaysia, marking the start of its planned greenfield manufacturing facility in Bandar Cassia Technology Park. The company is investing EUR...

BioTech

30 July, 2026 | Thursday | News

Eppendorf to Invest EUR 40 Million in New Penang Manufacturing Facility

Eppendorf has signed an agreement for a new production site in Penang, Malaysia, marking the start of its planned greenfield manufacturing facility in Bandar Cassia Technology Park. The company is investing EUR...

Contract Services

24 July, 2026 | Friday | News

Samsung Bioepis Secures Exclusive Commercial Rights to Nectin-4 ADC Candidate SBE303

Ÿ   Under the agreement, Samsung Bioepis will obtain exclusive commercial licensing rights to SBE303, an ADC candidate currently in joint development Ÿ   This agreement ...

Consumer Health

28 July, 2026 | Tuesday | News

Roche Secures US FDA Clearance for PCR Test Detecting Bacterial Vaginosis and Candida Vaginitis

The new PCR test uses clinician-collected or clinician-instructed, self-collected vaginal swab specimens to simultaneously detect organisms associated with Bacterial vaginosis (BV) and Candida ...

Medtech

28 July, 2026 | Tuesday | News

Advita Introduces Activit-E Vitamin E Polyethylene to Equinoxe Reverse Shoulder System

Advita Ortho, a global medical technology leader,  announced the first clinical use of humeral liners manufactured with Activit-E® polyethylene, bringing its advanced vitamin E polyethylene technology ...

Cell & Gene

24 July, 2026 | Friday | News

Tikva Allocell Raises $8M Series A to Advance Off-the-Shelf CAR-T Therapy for Solid Tumours

Funding will support completion of IND-enabling activities and planned year-end IND submission for TAVST01, Tikva's lead off-the-shelf CAR-T candidate targeting B7-H3-positive solid tumors Tikva Allocell Pte. ...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close